---

title: Neutropenic Fever and Cancer
authors:
    - Michelle Lin, MD
created: 2011/10/07
updates: null
categories:
    - Hematology and Oncology
---

# Neutropenic Fever and Cancer

Chemotherapy causes neutropenia in 10-50% of patients with solid tumors and > 80% of patients with hematologic malignancies during chemotherapy cycle

**Fever:** ≥ 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period

**Neutropenia:** Absolute neutrophil count &lt; 500 cells/mm3

## MASCC score

**Multinational Association for Supportive Care in Cancer (MASCC) Score:**

| Criteria                                                                                          |             Points             |
| ------------------------------------------------------------------------------------------------- | :----------------------------: |
| Burden of febrile neutropenia                                                                     | 5 (if mild) or 3 (if moderate) |
| No hypotension (SBP ≥ 90 mmHg)                                                                    |                5               |
| No COPD                                                                                           |               4                |
| Solid tumor or hematologic malignancy <span class="drug">with</span> no previous fungal infection |                4               |
| No dehydration requiring parenteral fluids                                                        |                3               |
| Outpatient status\*                                                                               |                3               |
| Age &lt;60 years\*                                                                                |                2               |

**HIGH RISK PATIENTS** (require admission):

-   MASCC score &lt; 21 **OR**
-   Any of clinical findings:
    -   Prolonged (>7 days duration) and profound neutropenia (ANC ≤ 100 cells/mm3)
    -   Hypotension
    -   Pneumonia
    -   New abdominal pain
    -   Neurologic changes

**LOW RISK PATIENTS** (may be eligible for outpatient tx):

-   MASCC score ≥21
-   Brief (≤7 days duration) neutropenic periods and few co-morbidities

## Workup

-   CBC, BUN/Creatinine, electrolytes, AST/ALT, bilirubin
-   Chest xray, if respiratory signs or symptoms
-   2 blood cultures (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)

## Antibiotic Treatment

_Monotherapy:_ 

-   Antipseudomonal beta-lactam (eg. <span class="drug">cefipime</span>, <span class="drug">carbapenem</span>, <span class="drug">pip-tazo</span>)
-   <span class="drug">Vancomycin</span> is not always indicated in cancer patients with a neutropenic fever.
-   Add **vancomycin** only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant _Strep pneumoniae_
-   _For penicillin allergy_: <span class="drug">Ciprofloxacin</span> + <span class="drug">clindamycin</span>, or <span class="drug">aztremonam</span> + <span class="drug">vancomycin</span>
-   _Oral medication options for outpatient_: <span class="drug">Ciprofloxacin</span> + <span class="drug">amoxicillin-clavulanate</span>

## Central line-associated blood stream infection (CLABSI)

**Remove catheter:** Consider removal if any of following: 

-   Caused by _S. aureus_, _P. aeruginosa_, fungi, mycobacteria
-   Tunnel infection
-   Pocket site infection
-   Septic thrombosis
-   Endocarditis
-   Sepsis with hemodynamic instability
-   Bacteremia despite ≥72 hours of antibiotics

**Keep catheter** and treat with antiobitics: If coagulase-negative staph

## References

-   [Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93.](http://www.ncbi.nlm.nih.gov/pubmed/21205990)
